A C Buck

Summary

Country: UK

Publications

  1. ncbi Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action
    A C Buck
    Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom
    J Urol 172:1792-9. 2004
  2. ncbi Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
    A C Buck
    Department of Nuclear Medicine, University of Ulm, Ulm, Germany
    J Nucl Med 42:721-5. 2001

Detail Information

Publications2

  1. ncbi Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action
    A C Buck
    Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom
    J Urol 172:1792-9. 2004
    ..This review was done to analyze the large number of in vivo and in vitro laboratory studies that have been performed with extracts of Serenoa repens to elucidate mechanism(s) of action...
  2. ncbi Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
    A C Buck
    Department of Nuclear Medicine, University of Ulm, Ulm, Germany
    J Nucl Med 42:721-5. 2001
    ..Thus, a PET tracer indicating cellular proliferation should better differentiate between cancer and inflammatory lesions than do metabolic markers such as FDG...